TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

about

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

Item

http://www.wikidata.org/entity/Q36790108

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@ast

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@en

type

Item

label

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@ast

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@en

prefLabel

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@ast

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@en

P1476

TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.

@en

P2093

Dragana Kopanja

http://www.w3.org/2001/XMLSchema#string

Pradip Raychaudhuri

http://www.w3.org/2001/XMLSchema#string

P2860

TGFβ signalling in context

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.

Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.

The TAK1-TRAF6 signalling pathway.

Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing.

Cross-talk between transforming growth factor-beta and Wingless/Int pathways in lung development and disease.

TGF-β signaling pathway as a pharmacological target in liver diseases.

PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3.

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2016.03.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27127775

http://www.w3.org/2001/XMLSchema#string

P932

4828751

http://www.w3.org/2001/XMLSchema#string